Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22967640 | 0.86 | KRAS (0.37) | — | |
| SCHEMBL24854345 | 0.86 | KRAS (0.37) | — | |
| SCHEMBL22967641 | 0.86 | KRAS (0.37) | — | |
| SCHEMBL24543198 | 0.86 | JAK3 (0.33) | JAK3BTK | |
| SCHEMBL22969920 | 0.84 | JAK3 (0.33) | JAK3BTK | |
| SCHEMBL23848394 | 0.84 | JAK3 (0.33) | JAK3BTK | |
| SCHEMBL22967484 | 0.84 | — | — | |
| SCHEMBL22967478 | 0.84 | — | — | |
| SCHEMBL22967932 | 0.83 | ELANE (0.37) | — | |
| SCHEMBL22967775 | 0.82 | ELANE (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210040089-A1 | KRAS MUTANT PROTEIN INHIBITORS | JACOBIO PHARMACEUTICALS CO., LTD. | 2021-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210040089-A1 | KRAS MUTANT PROTEIN INHIBITORS | KRAS, NRAS, APC | JAK3 2110/4885BTK 1285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.